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Abstract 
Introduction: Distinct physiological responses to exercise occur in the heavy and severe-
intensity domains, which are separated by the critical power or critical torque (CT). However, 
how the transition between these intensity domains actually occurs is not known.  We tested the 
hypothesis that CT is a sudden threshold, with no gradual transition from heavy- to severe-
intensity behavior within the confidence limits associated with the CT.  Methods: Twelve 
healthy participants performed four exhaustive severe-intensity trials for the determination of 
CT, and four 30-minute trials in close proximity to CT (one or two standard errors above or 
below each participant‟s CT estimate; CT–2, CT–1, CT+1, CT+2).  Muscle O2 uptake (m  O2), 
rectified EMG and torque variability and complexity were monitored throughout each trial, and 
maximal voluntary contractions with femoral nerve stimulation were performed before and after 
each trial to determine central and peripheral fatigue responses.  Results: The rates of change in 
fatigue-related variables, m  O2, EMG amplitude and torque complexity were significantly faster 
in the severe trials compared to CT–2. For example, the fall in maximal voluntary contraction 
(MVC) torque was –1.5 ± 0.8 N.m.min-1 in CT–2 vs. –7.9 ± 2.5 N.m.min-1 in the lowest severe-
intensity trial (S1; P < 0.05). Individual analyses showed a low frequency of severe responses 
even in the circa-CT trials ostensibly above the CT, but also the rare appearance of severe-
intensity responses in all circa-CT trials. Conclusion:  These data demonstrate that the transition 
between heavy- and severe-intensity exercise occurs gradually rather than suddenly. 
 
Keywords: muscle; metabolic rate; non-linear dynamics; fatigue 
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Introduction 
Critical torque (CT), the asymptote of the hyperbolic relationship between isometric joint 
torque and the time to task failure, is an important functional threshold (1,2).  Above the CT (or, 
analogously, the critical power, CP) it is not possible to achieve a metabolic steady state, in 
contrast to exercise performed below it (for reviews see 3,4).  This metabolic non-steady state is 
also associated with the development of peripheral fatigue at a rate proportional to the proximity 
of the torque or power requirements to the CT or CP (2), with peripheral fatigue developing ~4-5 
times faster above CT compared to that below (2,5).  At task failure during contractions above 
CT, the degree of peripheral fatigue is similar irrespective of the duration of the task, suggesting 
both the mechanisms of fatigue and the factors resulting in task failure are common at these 
contractile intensities (2, 5). 
 
Many physiological variables evidence a threshold change in behavior once CT/CP is 
exceeded, including muscle and pulmonary   O2 (6,7), muscle phosphorylcreatine, inorganic 
phosphate concentration and pH (8), blood and muscle [lactate] (9), and muscle fatigue-related 
variables (2,5,10).  Our most recent work has suggested that CT also represents a critical 
threshold for the fatigue-induced loss of knee extensor torque output complexity (that is, the 
structure of fluctuations in the torque time series; 5).  In both health and disease, physiological 
time series complexity has been suggested to be a key marker of system adaptability (11).  In the 
context of the neuromuscular system, a loss of complexity in torque or force time series with 
ageing, disease, or fatigue, has been interpreted as a loss of motor control (5,12). That it is only 
above the critical torque that the complexity of muscle torque is lost as fatigue develops suggests 
that torque complexity also represents a sensitive marker of the proximity to the CT (5).  Thus, 
 
AC
CE
PT
ED
from this perspective, the absence of steady state behavior in muscle metabolism and muscle 
  O2 (m  O2) above the critical torque/power is mirrored by a measurable loss of neuromuscular 
control.  Collectively, therefore, measures of muscle activity, metabolism, fatigue, and time 
series complexity can, individually and/or collectively, provide sensitive physiological signatures 
of the proximity of the exercise task to the critical torque/power. 
 
The threshold nature of the CT is well established, but the nature of the threshold itself is 
not.  Although CT or CP can be expressed to the nearest newton-metre or watt, the confidence 
limits associated with the point estimate are, at best, 5-10% of the value of CT/CP (2,10,13).  As 
a result, the intensity at which heavy exercise responses should cease to be observed is unclear, 
and investigators usually, and justifiably, prescribe exercise tasks outside these confidence limits 
to avoid such uncertainty.  Studies which have been performed at this critical threshold have 
returned equivocal results, with steady state (6) and non-steady state responses (14-16) being 
observed.  However, by definition, performing exercise exactly at the CP or CT is itself subject 
to the uncertainty in the parameter estimate: 50% of responses are likely to be above CP, and 
50% below (17). We state “likely” here because this is, in fact, supposition: the occurrence of 
heavy or severe-intensity behavior in close proximity to CT/CP has not yet been systematically 
studied. 
 
Distinguishing between behaviours that are consistent with heavy-intensity exercise 
versus those which are demonstrably severe is, theoretically, straightforward, since tasks 
performed below the CT should be fatigueless (1).  However, in two separate studies we have 
demonstrated that fatigue does develop below CT, albeit at a very slow rate (2,5).  Moreover, 
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exercise in the heavy domain is associated with attainment of a delayed steady state, such that 
variables will demonstrate a positive rate of change over time when measured after the initial 
transient response (17).  Nevertheless, the 4-5-fold faster rates of change observed in metabolic 
and fatigue-related variables above vs. below the CT, coupled with consistent responses 
observed below the CT (2,5,8) provides a clear framework within which to study exercise 
responses in relation to the CT.  Figure 1 illustrates purpose of the present investigation; namely, 
to characterize the physiological responses to tasks performed in close proximity to the CT, for 
which there is currently no data from our intermittent isometric contraction model.   
 
There are, we contend, two possible patterns of behaviour that could occur in close 
proximity to the CT: 1) if the CT is a precise threshold, and the confidence limits associated with 
the parameter estimate reflecting fitting error in the severe-intensity predicting trials then 
consistent severe-intensity behavior should be observed in close proximity to, but nonetheless 
above, the CT; 2) if CT is a precise threshold that varies day-to-day by an amount represented by 
the confidence limits, or if the CT is itself “smeared” across a band of torque or power output 
and cannot be said to represent a single point value, then a small range of torque requirements 
exist in which the physiological response is fundamentally unpredictable and highly sensitive to 
the initial state of the system. In this case, the CT would behave as a continuous phase transition 
rather than a threshold (for a review of these general concepts, see 18).  In other words, in close 
proximity to CT, severe-intensity behavior would be observed where heavy-intensity responses 
should be seen (<CT), and heavy-intensity responses where severe-intensity responses would be 
expected (>CT).  
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The purpose of the present study was, therefore, to determine whether the CT is a sudden 
threshold or a gradual transition from heavy to severe-intensity exercise.  The specific 
experimental hypothesis tested was that the CT represents a sudden threshold, with no gradual 
transition from heavy- to severe-intensity behavior within the confidence limits associated with 
the CT.  
 
Methods 
Participants 
Twelve healthy participants (7 male, 5 female; mean ± SD: age 24.7 ± 4.8 years; height 
1.74 ± 0.09 m; body mass 69.1 ± 11.7 kg) provided written informed consent to participate in the 
study, which was approved by the ethics committee of the University of Kent (Prop 
10_2017_18), conformed to the standards set by the Declaration of Helsinki, except for 
registration in a database. Participants were instructed to arrive at the laboratory in a rested state 
(having performed no strenuous exercise in the preceding 24 hours) and to have consumed 
neither any food nor caffeinated beverages in the 3 hours before arrival. Participants attended the 
laboratory at the same time of day (± 2 hours) during each visit. 
 
Experimental design 
Participants were required to visit the laboratory on nine occasions over a 5-9-week 
period, with a minimum of 48 hours between each visit. During their first visit, participants were 
familiarized with all testing equipment and procedures, and the settings for the dynamometer and 
stimulator were recorded. During visits 2-5, participants performed a series of intermittent 
isometric contractions to task failure (see Severe trials below). From these four tests, the CT was 
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calculated, and participants subsequently performed four further tests, during visits 6-9, just 
below and just above the calculated CT (see Circa-CT trials below) for 30 minutes or until task 
failure, whichever occurred sooner. In each trial, torque output was sampled continuously to 
allow the quantification of complexity, muscle activity was measured using the vastus lateralis 
electromyogram (EMG), muscle oxygen consumption (m  O2) was measured using near-infrared 
spectroscopy (NIRS), and maximal voluntary contractions (MVCs) with supramaximal femoral 
nerve stimulation were used to quantify global, central and peripheral fatigue. 
  
Dynamometry 
During all visits, participants were seated in the chair of a Cybex isokinetic dynamometer 
(HUMAC Norm; CSMi, Massachusetts, USA), initialized and calibrated according to the 
manufacturer‟s instructions. Their right leg was attached to the lever arm of the dynamometer, 
with the seating position adjusted to ensure that the lateral epicondyle of the femur was in line 
with the axis of rotation of the lever arm. Participants sat with relative hip and knee angles of 85° 
and 90°, respectively, with full extension being 0°. The lower leg was securely attached to the 
lever arm above the malleoli with a padded Velcro strap, while straps secured firmly across both 
shoulders and the waist prevented any extraneous movement and the use of the hip extensors 
during the isometric contractions. The seating position was recorded during the first visit and 
replicated during each subsequent visit. 
 
Femoral nerve stimulation 
Electrical stimulation of the right femoral nerve was used to assess neuromuscular fatigue 
processes, in the same way as described by Pethick et al. (12). The anode, a carbon rubber 
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electrode with adhesive gel (100 × 50 mm; Phoenix Healthcare Products Ltd., Nottingham, UK), 
was placed lateral to the ischial tuberosity, on the posterior aspect of the leg. The position of the 
cathode was established using a motor point pen (Compex; DJO Global, Guildford, UK), and 
determined based on the location in the femoral triangle giving the largest twitch and greatest 
peak-to-peak amplitude of the compound muscle action potential (M-wave) following single 
stimulation at 100 mA, using a constant-current variable voltage stimulator (Digitimer DS7AH, 
Welwyn Garden City, UK). Following establishment of the precise cathode location, an 
Ag/AgCl electrode (32 × 32 mm; Nessler Medizintechnik, Innsbruck, Austria) coated in 
conductive gel was placed over the femoral nerve. 
 
The appropriate stimulator current was then established by incrementally increasing the 
current (in steps of 20 mA) until knee extensor torque and the M-wave response to single 
twitches had plateaued. This was verified with stimulation delivered during a contraction at 50% 
MVC to ensure a maximal M-wave during an isometric contraction was also evident. Once this 
was obtained, the stimulator current was then increased to 130% of the current producing a 
maximal M-wave (mean ± SD, 338 ± 88 mA). In all subsequent trials, doublet stimulation (two 
200 µs pulses with 10 ms interpulse interval) was used. 
 
Surface EMG 
The EMG of the vastus lateralis was sampled using Ag/AgCl electrodes (32 × 32 mm; 
Nessler Medizintechnik, Innsbruck, Austria). Prior to attachment of the electrodes, the skin of 
the participants was shaved, abraded and then cleaned with an alcohol swab over the belly of the 
muscle, in order to reduce impedance. The electrodes were placed on the prepared skin over the 
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belly of the muscle in a direction parallel to the alignment of the muscle fibres. A reference 
electrode was placed on the prepared skin medial to the tibial tuberosity. Care was taken to 
ensure that the electrode locations were similar between sessions by visual inspection and 
palpation of the muscle belly during a light contraction. The raw EMG signals were sampled at 1 
kHz, amplified (gain 1000) and band-pass filtered (10-500 Hz; Biopac MP 150; Biopac Systems 
Inc., California, USA). 
 
Muscle oxygen consumption 
The m  O2 from the vastus lateralis was obtained using a continuous-wave NIRS device 
(Oxymon Mk III, Artinis Medical Systems, Netherlands), calibrated according to the 
manufacturer‟s instructions before each trial. The NIRS device generated light at three 
wavelengths (905, 850 and 770 nm) corresponding to the absorption wavelengths of 
oxyhaemoglobin (O2Hb) and deoxyhaemoglobin (HHb). An area at the level of the largest 
circumference of the vastus lateralis was shaved, abraded and cleaned with an alcohol swab. The 
NIRS optode was then placed at this location and secured with Velcro straps and biadhesive tape, 
such that the optode did not move during contraction. A blood pressure cuff (Hokanson E20 cuff 
inflator; D.E. Hokanson Inc., Bellevue, USA) was placed proximal to the NIRS optode, and was 
used to maintain blood volume under the optode during measurement. NIRS data were collected 
at 10 Hz. Adipose tissue thickness at the site of measurement was assessed, as per the 
recommendations of Ferrari et al. (19), using skinfold callipers. However, as demonstrated in 
Ryan et al. (20), an ischaemic calibration eliminates any effect of adipose tissue thickness and 
scales the NIRS signals according to the maximal physiological range. 
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Protocol 
All visits followed a pattern of data acquisition similar to that previously reported (21). 
Each visit began with the instrumentation of the participants and the establishment of the correct 
dynamometer seating position and supramaximal stimulation response. Participants then 
performed a series of brief (3 second) MVCs to establish their maximum torque. These 
contractions were separated by a minimum of 60 seconds rest, and continued until the peak 
torques in three consecutive contractions were within 5% of each other. Participants were given a 
countdown, followed by very strong verbal encouragement to maximize torque. The first MVC 
was used to establish the fresh maximal EMG signal, against which the subsequent EMG signals 
were normalized (Data analysis; see below). The second and third MVCs were performed with 
femoral nerve stimulation delivered during the contraction and at rest after the contraction. The 
stimulation during the contraction was delivered during a plateau in maximal torque, in order to 
test the maximality of the contraction and provide the resting voluntary activation; while the 
stimulation at rest was delivered 2 seconds after the contraction, in order to establish the fresh 
potentiated doublet torque. All subsequent contractions with femoral nerve stimulation were 
conducted in this manner. 
  
After the establishment of maximum torque, the resting m  O2 of the vastus lateralis was 
assessed based on the decrease in muscle oxygenation which accompanies an arterial occlusion 
(20,22). For this, the blood pressure cuff was inflated to 300 mmHg using a Hokanson AG101 
(D.E. Hokanson Inc., Bellevue, USA). Four resting measurements were made using 10 seconds 
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of arterial occlusion, each separated by 60 seconds rest. The resting m  O2 was calculated using 
linear regression with the first 8 seconds of each occlusion (Data analysis; see below). 
Participants then rested for 10 minutes before performing the experimental trial (see below). 
 
Severe trials 
During visit 2 (the first of the severe trials), the highest instantaneous pre-test measure of 
voluntary torque was recorded as the peak MVC torque, and the target torques for the 
submaximal contractions in visits 2-5 were calculated from this value. The submaximal 
contractions were performed, as in our previous studies (5,12) using a duty cycle of 0.6, with 
contractions held for 6 s, followed by 4 s rest. The target for the submaximal contractions in visit 
2 was set at 50% of the peak torque measured in the pre-test MVCs. Participants were instructed 
to match their instantaneous torque with a target bar superimposed on the display in front of 
them and were required to continue matching this torque for as much of the 6 s contraction as 
possible. The test was conducted until task failure, the point at which the participant failed to 
reach the target torque on three consecutive contractions, despite strong verbal encouragement. 
Participants were not informed of the elapsed time during the test, but were informed of each 
“missed” contraction. After the third missed contraction, participants were instructed to produce 
an MVC, which was accompanied by peripheral nerve stimulation. 
 
At the end of each minute (i.e. after every fifth contraction), m  O2 was assessed, as 
described in Pethick et al. (21). The blood pressure cuff was inflated to 300 mmHg for 5 
seconds, with m  O2 calculated using linear regression over the course of this occlusion. This 
measure of m  O2 was performed instead of a targeted contraction. m  O2 was also assessed 
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immediately prior to the MVC performed at task end/failure. Five minutes after task end/failure, 
an ischaemia/hyperaemia calibration was performed to normalize the NIRS signals. The blood 
pressure cuff was inflated to 300 mmHg for 3-5 minutes (or until the NIRS signals plateaued). 
This deoxygenated the tissue under the optode (defined as 0% oxygenation), while the peak 
hyperaemic response upon release of the cuff was assigned a value of 100% oxygenation.   
 
The duration of the initial severe trial at 50% MVC was used to determine the percentage 
of MVC used in the subsequent three trials, which were performed in an identical manner. The 
objective of these trials was to yield times to task failure of between 2 and 15 minutes, which 
have been recommended for the assessment of CT (23). The subsequent severe trials were 
performed in a randomized order. Visits 2-5 were used to determine the CT. The individual trials 
were identified as severe 1 (S1) to severe 4 (S4), with S1 and S4 being the lowest and highest 
torques, respectively. 
 
Circa-CT trials 
The final four visits were performed at target torques based on the standard error (SE) of 
the calculated CT. The target torques were two SE below the CT (CT–2), one SE below the CT 
(CT–1), one SE above the CT (CT+1) and two SE above the CT (CT+2). Thus, by design, each 
of these trials was within the 95% confidence limits of the CT parameter estimate, but below or 
above the point estimate.  These trials were conducted in the same manner as the severe trials, 
requiring participants to perform intermittent contractions (6 s on, 4 s off) at a target torque. In 
these trials, the contractions were performed for 30 minutes or until task failure, whichever 
occurred sooner. These four circa-CT trials were performed in a randomized order. No trials 
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were performed exclusively below CT due to the already heavy time commitment on the part of 
the participants (nine laboratory visits of up to 2 hours each), so as to maximize the granularity 
of the circa-CT analysis. As a result, the responses to the circa-CT trials were compared to our 
previously published studies (see Figure 1) to establish whether those response profiles 
approximated heavy exercise. 
 
Data acquisition and participant interface 
Data acquisition was performed in a similar manner as previously described (21). Briefly, 
the isokinetic dynamometer, stimulator and EMG were connected via BNC cables to a Biopac 
MP150 (Biopac Systems Inc., California, USA) and a CED Micro 1401-3 (Cambridge Electronic 
Design, Cambridge, UK) interfaced with a personal computer. These data were sampled at 1 kHz 
and collected in Spike2 (Version 7; Cambridge Electronic Design, Cambridge, UK). The NIRS 
data were sampled at 10 Hz and collected in OxySoft (Artinis Medical Systems, Netherlands).  
 
A chart containing the instantaneous torque was projected onto a screen placed ~1 m in 
front of the participant. A scale consisting of a thin line (1 mm thick) was superimposed on the 
torque chart and acted as a target, so that participants were able to match their instantaneous 
torque output to the target torque during each visit.  
 
Data analysis 
All data were analyzed using code written in MATLAB R2017a (The MathWorks, 
Massachusetts, USA). The data analysis focused on five areas: 1) basic measures of torque and 
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EMG; 2) calculation of CT; 3) measures of central and peripheral fatigue; 4) the variability and 
complexity of torque output; and 5) measures of m  O2. 
 
Torque and EMG: The mean and peak torque for each contraction in each trial were 
determined. The mean torque was calculated based on the steadiest five seconds of each 
contraction, with MATLAB code identifying the five seconds of each contraction with the lowest 
standard deviation. The point of task failure was determined as described previously (12). The 
mean torque produced during the first five contractions was calculated, with task failure deemed 
to occur when the mean torque recorded during three consecutive contractions was more than 5 
N·m below the mean torque of the first five contractions, with the first of these contractions 
being considered the point of task failure. 
 
The EMG output from the vastus lateralis for each contraction was full-wave rectified 
during each five second window. The average rectified (arEMG) was then calculated and 
normalized by expressing the arEMG as a fraction of the arEMG obtained during an MVC from 
the fresh muscle performed at the beginning of the trial. 
 
Critical torque: CT was determined as in Pethick et al. (5). The total torque impulse 
produced until task failure and the total contraction time during each individual trial were 
calculated. The torque impulse was then plotted against the contraction time, and the parameters 
of the torque-duration relationship were estimated using linear regression of the torque impulse 
vs. contraction time (2):  
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[1] 
 
where W′ represents the curvature constant parameter and t is the time to task failure. 
 
Central and peripheral fatigue: Measures of central and peripheral fatigue were 
calculated based on the stimuli delivered during and after the MVCs performed pre-test and at 
task end/failure. Peripheral fatigue was evidenced by a fall in the potentiated doublet torque. 
Central fatigue was evidenced by a decline in voluntary activation, quantified using the twitch 
interpolation technique (24,25): 
 
                     ( )  (                                     )       ⁄  
[2] 
 
where the superimposed doublet was that measured during the contraction of interest and 
the potentiated doublet was measured at rest 2 seconds after that contraction. 
 
Variability and complexity: All measures of variability and complexity were calculated 
using the steadiest five seconds of each contraction, identified by MATLAB as the five seconds 
containing the lowest standard deviation (SD). The amount of variability in the torque output of 
each contraction was measured using the SD and coefficient of variation (CV). The SD provides 
a measure of the absolute amount of variability in a time-series, while the CV provides a 
measure of the amount of variability in a time-series normalized to the mean of the time series. 
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 The temporal structure, or complexity, of torque output was examined using multiple 
time domain analyses. The regularity of torque output was determined using approximate 
entropy (ApEn; 26) and the temporal fractal scaling of torque was estimated using the detrended 
fluctuation analysis (27) α scaling exponent (DFA α). The calculations of ApEn and DFA are 
detailed in Pethick et al. (21). In brief, ApEn was calculated with the template length, m, set at 2 
and the tolerance, r, set at 10% of the SD of torque output, and DFA was calculated across time 
scales (57 boxes ranging from 1250 to 4 data points).  If crossover in the DFA analysis was 
identified in the log-log plot of fluctuation size versus box size (as shown by an r < 0.95), an 
iterative piecewise least squares linear regression was used to fit two lines to the plot for these 
trials, and two α exponents were quantified.  The second of these (α2, representing longer, 
physiologic timescales) was used in the DFA α exponent analysis (21). Ten cases of crossover 
occurred during the circa-CT trials (out of 48 trials), and none during the severe-intensity 
predicting trials. 
 
Muscle oxygen consumption  m  O2 was determined as described in Ryan et al. (20,22). 
m  O2 was calculated as the slope of the change in O2Hb and HHb during arterial occlusion 
using simple linear regression. The resting m  O2 measurement was based on the first 8 seconds 
(80 data points) of a 10 second arterial occlusion, while the exercising m  O2 measurements were 
based on a 5 second arterial occlusion (50 data points).  
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The NIRS data were corrected for blood volume changes (20,22) using custom-written 
MATLAB code. A blood volume correction factor (β) was calculated for each data point during 
the arterial occlusions: 
 
 ( )   
|    ( )|
(|    ( )|   |   ( )|)
  
[3] 
where β is the blood volume correction factor, t is time, O2Hb is the oxygenated 
haemoglobin/myoglobin signal, and HHb is the deoxygenated haemoglobin/myoglobin signal. 
Each data point was corrected using its corresponding β according to Eqs. 4 and 5, below.  
 
     ( )       ( )   [   ( )    (    )] 
[4] 
    ( )     ( )   [   ( )     ] 
[5] 
 
where O2Hbc and HHbc are the corrected oxygenated and deoxygenated 
haemoglobin/myoglobin signals, respectively; tHb is the blood volume signal from the NIRS 
device; β is the blood volume correction factor; and t is time. The raw O2Hb signal in equation 4 
is corrected by subtracting the proportion of the blood volume change attributed to O2Hb; while 
in equation 5 the raw HHb signal is corrected by subtracting the proportion of blood volume 
change attributed to HHb. 
 
Rates of change 
 
AC
CE
PT
ED
To identify heavy- or severe-intensity behavior in m  O2, arEMG and fatigue and 
complexity-related variables, we first calculated the rate of change in CT–2 from the second 
minute of exercise until task failure or task completion (30 minutes) - in order to avoid 
contamination of the primary kinetics of m  O2 - and compared this to the equivalent rates of 
change in all other circa-CT trials.  Specifically, the rate of change in CT–2 for each individual 
participant was subtracted from their rates of change in each other condition, assuming that CT–
2 most likely represented heavy-intensity exercise.  Severe-intensity exercise was then deemed to 
have occurred if the resulting “normalized” rate of change was 2 SD greater than that 
individual‟s CT–2 value, where the SD was the SD of the rate of change in CT–2 (as reported in 
Tables 1 and 2).  Thus, if a participant‟s responses to CT–1, CT+1 and CT+2 exceeded the 2 SD 
criterion, they were considered severe-intensity, but if below it they were considered heavy.  We 
accept that this value is arbitrary, but in the absence of any agreed quantitative definition of 
heavy-intensity behavior we suggest this “2 σ” approach provides an objective and justifiable 
metric. Using criterion values greater than 2 SD are likely to result in misclassification (i.e., 
misclassifying severe-intensity exercise as heavy). 
 
Statistics 
All data are presented as means ± SD unless otherwise stated. The S4 trial was used only 
for the purposes of determining CT and was excluded from all further analysis. This was due to 
its relatively short duration making the calculation of rates of change impossible. Two-way 
analysis of variance (ANOVAs) with repeated measures were used to test for differences 
between conditions and time points, and for a condition × time interaction for MVC torque, 
arEMG, potentiated doublet torque, voluntary activation, variability, complexity and m  O2. The 
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variability, complexity and m  O2 measures were analyzed using means from the second minute, 
to account for the primary kinetics of the   O2 response (28) and final minute before task 
end/failure. When main effects were observed, Bonferroni-adjusted 95% paired-samples 
confidence intervals were used to identify specific differences. The rates of change in all 
variables were analyzed using Student‟s paired-samples t-tests.  
 
Results 
Preliminary Measures and the CT 
The peak instantaneous MVC torque recorded during an MVC in visit 2 was 233.4 ± 66.7 
N.m. This was used to set the target torques for the tests performed above CT, which are 
presented in Table 1. The CT was calculated to be 61.4 ± 15.2 N·m, which was equivalent to 
26.7 ± 3.0% MVC, and the Wʹ was 4,800 ± 1428 N·m·s. The 95% confidence interval (CI) for 
the estimation of CT was 8.9 ± 2.8 N·m. The torque requirements for the circa-CT trials were 
determined as one or two standard errors below or above CT (i.e., within the 95% confidence 
limits of CT; Table 1). 
 
Torque, muscle oxygen consumption and EMG 
For the trials above the CT, task failure occurred when participants were no longer able to 
achieve the target torque, despite a maximal effort. All trials above the CT resulted in significant 
decreases in MVC torque (F = 140.80, P < 0.001), with the mean MVC torque at task failure 
being not significantly different from the torque produced during the submaximal contractions 
(Table 1). In contrast, all participants completed 30 minutes of contractions (with the exception 
of one trial in CT+2) in the Circa-CT trials. At the end of these trials, the mean MVC torque was 
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still significantly greater than the submaximal torque requirements (95% paired samples CIs: 
CT–2, 89.4, 131.3 N·m; CT–1, 74.9, 130.6 N·m; CT+1, 58.9, 108.3 N·m; CT+2, 39.5, 95.9 
N·m), indicating that the contractions ended with a substantial reserve in maximal torque. MVC 
torque remained significantly greater at task end in CT–2 compared with task end/failure in 
CT+2 (CIs: 1.5, 67.1 N·m), S1 (CIs: 60.9, 102.4 N·m), S2 (CIs: 44.0, 93.6 N·m) and S3 (CIs: 
39.5, 78.2 N·m).  The rate of change in MVC torque was greater for CT+1 and all severe-
intensity trials (S1-S3) compared to CT–2 (Table 1).   
After the initial transient, all of the trials resulted in significant increases in m  O2 (F = 
257.03, P < 0.001; Figure 2). The m  O2 at task end in CT–2 remained significantly lower 
compared with task end/failure in CT+1 (CIs: –1.6, –0.04), CT+2 (CIs: –1.7, –0.6 %·s-1), S1 
(CIs: –2.2, –0.3 %·s-1), S2 (CIs: –2.8, –0.3 %·s-1) and S3 (CIs: –2.2, –0.5 %·s-1). The arEMG 
amplitude increased over time in all of the trials above CT, reaching ~68-80% of the pre-test 
MVC value at task failure (F = 58.30, P < 0.001; Figure 2, Table 2). The Circa-CT trials also 
resulted in increases in arEMG as the trials progressed, though these were more modest than for 
the trials above the CT (Table 1). The arEMG remained significantly lower at task end in CT–2 
compared with task end/failure in CT+1 (CIs: –15.5, –5.2%), CT+2 (CIs: –25.8, –7.9%), S1 
(CIs: –49.4, –24.5%), S2 (CIs: –48.6, –35.0%) and S3 (CIs: –55.3, –43.2%).  The rates of change 
for the Circa-CT trials did not differ from CT–2, whereas all trials above the CT had greater rates 
of change than CT–2 for both m  O2 and arEMG (Table 2).  Figure 3 shows the individual rates 
of change in m  O2 and arEMG normalized to the rates of change in the CT–2 trial for the Circa-
CT trials and S1.  None of the Circa-CT demonstrated consistent severe-intensity behavior in 
either parameter (defined as a rate of change 2 SD greater than the CT–2 mean value), although 
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1-5 participants exceeded this threshold value during these trials. The majority of individual 
responses to the S1 trial were correctly classified as severe-intensity (Figure 3A and B).  
 
Peripheral and central fatigue 
All of the trials above the CT resulted in significant reductions in potentiated doublet 
torque (F = 65.60, P < 0.001; Table 1), indicating the presence of peripheral fatigue. The Circa-
CT trials also resulted in modest, though significant, reductions in potentiated doublet torque 
(Table 1). The potentiated doublet torque remained significantly greater at task end in CT–2 
compared with task end/failure in CT+2 (CIs: 0.07,15.0 N·m), S1 (CIs: 10.7, 31.9 N·m), S2 (CIs: 
3.1, 37.2 N·m) and S3 (CIs: 5.9, 33.3 N·m). Voluntary activation significantly decreased during 
all trials above the CT (F = 37.02, P < 0.001; Table 1), indicating the presence of central fatigue. 
The Circa-CT trials also resulted in modest, though significant, decreases in voluntary activation 
(Table 1). Voluntary activation remained significantly greater at task end in CT–2 compared with 
task failure in S1 (CIs: 8.2, 28.8%), S2 (CIs: 6.1, 17.1%) and S3 (CIs: 7.8, 16.6%).  There was a 
greater rate of change in potentiated doublet torque during CT+1, CT+2 and all other trials above 
the CT compared to CT–2.  The individual rates of change in the MVC and potentiated doublet 
torque are presented in Figure 3.  As above for m  O2 and arEMG, there were no consistent 
severe-intensity responses to the circa-CT trials, although severe-intensity behavior was 
inconsistently observed for both variables.  In contrast, all participants demonstrated correctly 
classified severe-intensity responses to the S1 trial.  
 
Variability and complexity 
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The variability and complexity data are presented in Table 2. The amount of variability, 
as measured by the SD (F = 60.29, P < 0.001) and CV (F = 78.56, P <0.001), increased in all 
trials. The SD and CV remained significantly lower at task end in CT-2 compared with task 
failure in S1 (CIs: SD, –5.2, –0.9 N·m; CV, –5.4, –1.1%), S2 (CIs: SD, –6.0, –1.4 N·m; CV, –
5.2, –1.3%) and S3 (CIs: SD, –8.7, –3.7 N·m; CV, –9.3, –1.7%).  
 
Complexity decreased throughout all trials, as measured by ApEn (F = 132.11, P < 
0.001) and DFA α (save CT–2; F = 28.98, P < 0.001, Figure 2, Table 2). ApEn decreased over 
the course of all severe trials, but remained significantly greater at task end in CT–2 compared 
with task failure in S1 (CIs: 0.3, 0.5), S2 (CIs: 0.2, 0.5) and S3 (CIs: 0.3, 0.6). DFA α increased 
over the course of all the above CT trials, and remained significantly lower at task end in CT–2 
compared with task failure in S1 (CIs: –0.2, –0.1), S2 (CIs: –0.3, –0.1) and S3 (CIs: –0.4, –0.2). 
There was no difference in the rates of change between the Circa-CT trials, but all trials above 
CT showed a greater rate of change than CT–2 (Table 2). The individual rates of change are 
presented in Figure 3.  Severe-intensity behavior was inconsistently observed during the Circa-
CT trials for both ApEn and DFA α, but the majority of cases appeared to be responses in the 
heavy domain.  In contrast, all of the responses to S1 were clearly placed in the severe-intensity 
domain.   
 
Discussion 
The principal original finding of the present study was that exercise tasks in close 
proximity to the critical torque did not show evidence of a sudden fatigue, neuromuscular, 
metabolic or physiological complexity threshold at the CT, in contrast to our first hypothesis.  
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Specifically, we did not observe consistently severe-intensity behavior in m  O2, arEMG, 
fatigue-related variables (MVC, potentiated doublet, and voluntary activation), or torque 
complexity two standard errors above the CT (~107% of CT).  In contrast, the lowest severe-
intensity task (~139% CT) showed clear evidence of severe-intensity behavior in the above 
variables.  Nevertheless, there was some evidence of severe-intensity responses in some 
individuals exercising close to the CT, suggesting that the physiological responses to exercise 
within the confidence limits of the CT are unpredictable. The CT therefore appears to represent a 
band of torque values rather than a precise point estimate, akin to a form of continuous phase 
transition between heavy and severe intensity exercise. Thus, we provide the first evidence that 
the CT, whilst representing a metabolic and fatigue threshold in the context of separating distinct 
intensity domains, the transition itself is not sudden but is rather smeared across a band of torque 
represented by the 95% confidence limits of the CT parameter estimate. 
 
Typical responses observed in the heavy and severe-intensity domains 
There is no question that distinct physiological responses can be observed across the 
exercise intensity spectrum, with experimentally identifiable physiological landmarks separating 
at least four exercise intensity domains (7,28,29).  In previous studies, we have demonstrated that 
exercise performed below the CT eventually results in stable responses (in arEMG), very slowly 
developing peripheral fatigue (2) and no change in torque output complexity (5).  For tasks 
requiring >110% CT, distinctly different fatigue mechanisms, muscle metabolic responses, and 
adaptations in neuromuscular control occur (2,5,8).  Specifically, severe-intensity exercise is 
characterized by non-steady state metabolic and neuromuscular responses, and exercise tolerance 
is usually limited to less than ~30 minutes (e.g., 2,6,8).  All severe-intensity trials in the present 
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experiments shared these characteristics: both m  O2 and arEMG increased systematically until 
task failure occurred (in less than ~20 minutes; Figure 2, Table 2).  The fall in MVC was such 
that at task failure a maximal contraction was required to produce the required torque, and the 
potentiated doublet torque had declined to consistently low values (Table 1). Central fatigue was 
also evident, with voluntary activation falling by approximately 10%, consistent with previously 
reported responses (2,5).  The severe-intensity trials were also associated with substantial 
reductions in torque steadiness (torque SD or C ) and torque complexity (ApEn or DFA α 
exponent; Table 2, Figure 2) as previously reported (5). 
 
 
Behavior in close proximity to the critical torque 
The central aim of the present study was to determine how these adjustments behaved in 
very close proximity to the CT.  If the CT is a sudden threshold, with the confidence limits 
simply representing a fitting error in the linear regression of the torque-time integral (as a result 
of variance in severe-intensity performance within the predicting trials), severe-intensity 
behavior should have been absent in all tasks below CT, and present in all tasks above CT. The 
present study lacked a condition that was demonstrably below the CT.  This was a deliberate 
design choice to focus on the responses within the 95% confidence limits of the CT whilst 
keeping the demands on the participants for repeated testing to a minimum (the present 
experiments required 9 laboratory visits lasting approximately 2 hours each).  Our previous work 
on this issue in comparable cohorts again provides a useful point of reference (2,5).  The 
responses to the CT–2 condition in the present study (performed at ~93% CT) were virtually 
identical to those responses to a trial at 90% CT in the study of Pethick et al. (5, their Tables 1 
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and 2, present study Figure 4).  For example, in our two previous studies the rate of fall in 
potentiated doublet below the CT has never exceeded 0.9 N.m.min
-1
.  The largest rate of decline 
in this variable in CT–2 was 0.5 N.m.min-1. 
 
In contrast to the severe-intensity responses, the CT–2 trial was associated with only 
small (but statistically significant) changes in m  O2, the MVC, and voluntary activation.  Each 
of these were significantly smaller in magnitude than those recorded in the severe-intensity trials 
and, at the end of the task (30 min) there was a significant reserve in torque-generating capacity 
(MVC).  Similarly, the changes in torque steadiness and complexity, which were small but 
statistically significant, did not reach values observed at task failure in the severe-intensity trials.  
Importantly, compared to CT–2, all severe-intensity trials showed greater fatigue-related 
responses at task failure (in m  O2, arEMG, MVC, potentiated doublet, VA, torque steadiness 
and complexity), indicating that the severe-intensity tasks were performed in a different region of 
the exercise intensity spectrum than CT–2.  Thus, despite its close proximity to the CT, all of the 
evidence, from the present and previous studies, demonstrates that CT–2 was performed in the 
heavy-intensity domain. 
 
If the CT represents a sudden threshold, then the two trials performed above the CT 
(CT+1 and CT+2) should have produced severe-intensity exercise responses.  Several parameters 
showed statistically significant changes in the CT+1 and/or CT+2 trials compared to CT–2 
(Table 1, Table 2).  For example, MVC and potentiated doublet torque decreased to a greater 
degree in CT+1 and CT+2 compared to CT–2 (Table 1), and m  O2 and arEMG were both 
significantly higher after 30 min above CT compared to CT–2 (Table 2).  In addition, the rate of 
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increase in m  O2 was also higher in CT+1 but not CT+2.  Finally, the rate of change in MVC 
torque was higher in CT+1 than CT–2, and the rate of change in the potentiated doublet, an index 
of peripheral fatigue, was higher in both CT+1 and CT+2.  However, differences between the 
CT+1 and CT+2 trials compared to CT–2 would be expected simply on the basis that the former 
trials were performed at a higher absolute torque requirement.  Of greater importance is whether 
or not the responses observed were demonstrably in the severe-intensity domain, which would be 
expected if the CT is indeed a sudden physiological threshold. 
 
In lieu of a rigorous classification for steady state and non-steady state behavior in the 
variables measured in the present study (cf. the blood lactate response to exercise; 17), we 
attempted to further differentiate heavy- and severe-intensity exercise by considering any 
individual rate of change two standard deviations greater than that of the mean in CT–2 to 
indicate severe-intensity exercise.  These analyses (Figure 3) revealed that severe-intensity 
behavior in m  O2, arEMG, MVC, potentiated doublet and torque complexity could be observed, 
on occasion, in CT–1 as well as CT+1 and CT+2.  Moreover, responses within an individual 
sometimes differed across the circa-CT trials (e.g., severe-intensity behavior being observed in 
CT+1 but not CT+2; Figure 3C). Nevertheless, the majority of participants‟ responses in the 
CT+1 and CT+2 trials were indicative of heavy-intensity domain behavior.  In the CT+2 trial, at 
most only 3-5 participants produced demonstrably severe-intensity responses for each variable, 
and the identity of these participants also varied.  The sensitivity of the individual analysis is 
supported by the contrasting results of the S1 analysis  only one response for arEMG and three 
for m  O2 were misclassified as heavy exercise (Figure 3A and B). All of the fatigue and torque 
complexity responses were correctly classified as severe.  Such a low occurrence of severe-
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intensity responses in the CT+1 and CT+2 trials was unexpected, and thus these data 
demonstrated that the CT is not a sudden threshold.  Instead, the confidence limits associated 
with this parameter appear to reflect a band of physiological uncertainty, wherein different 
system states can coexist and the responses observed cannot be predicted (that is, a continuous 
phase transition; 2,18).  
 
Physiological basis of the phase transition 
The data of the present study demonstrate that the transition from heavy-intensity to 
severe-intensity behavior appears to occur gradually over ~5% of the MVC.  This is illustrated in 
Figure 4, which presents rate of change in the potentiated doublet torque in this study and each of 
our previous investigations of the CT concept.  That such a transition was collectively reflected 
in markers of muscle activation, muscle metabolic rate, indices of neuromuscular fatigue, and 
torque complexity, with none of these changes preceding the others implies that the underlying 
mechanism(s) of this transition is likely to be common to all of these factors.  Importantly, whilst 
most responses within 2 standard errors of the CT were likely to be characterized as heavy-
intensity exercise, severe-intensity responses were observed, albeit rarely, in all trials.  This 
implies that the responses to exercise “at” CT/CP (i.e., within the 95% confidence limits of 
CT/CP) are unpredictable, which is supported by the inconsistent responses to exercise 
performed at CP reported previously (6,14,15).  It is known that the critical power is correlated 
with the proportion of type I muscle fibres (9), and it has been shown repeatedly that the CP is 
sensitive to O2 delivery (30,31). Moreover, CP is correlated with indices of muscle capillary 
density, particularly around type I muscle fibres (13).  Most recently, it has been shown that CP 
declines following prolonged exercise (32), a decline that is blunted by ingestion of 
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carbohydrates (33). Thus, CT/CP seems to be determined, in part, by muscle fibre properties and 
the supply of substrates and O2 to them, and therefore the mechanism(s) responsible for the 
phase transition we propose here likely involves these factors too. 
 
It is known that there are spatial and temporal heterogeneities in muscle metabolism 
(34,35,36) and muscle oxygenation (37), the latter reflecting the dynamic balance between 
microvascular O2 delivery and mitochondrial O2 consumption (see 38 for review).  Thus, those 
factors above thought to determine the CP are subject to spatial and temporal variation in activity 
and substrate supply.  We suggest that such heterogeneities may also explain the apparent phase 
transition that occurs around CT.  Specifically, the band of intensities represented by the CT is, 
by definition, a region wherein the neuromuscular system is precariously balanced between 
heavy and severe exercise. Subtle variations in motor unit recruitment, metabolism, and blood 
flow within trials, or between days, may result in the system being tripped into the severe domain 
when it would be expected to be in the heavy domain and vice versa.  Indeed, James and Green 
(39) produced realistic power-duration curves during constant load and all-out exercise by 
modelling the effect of fatigue on the motor unit pool.  The importance of this is that the above 
heterogeneities could increase the probability of motor units developing functionally significant 
levels of fatigue, leading to the recruitment of additional, and even less fatigue-resistant motor 
units.  In other words, the phase transition we propose is a small region of the intensity spectrum 
in which the probability of unsustainable fatigue and resulting non-steady state behavior 
developing significantly increases.  However, it is only in the severe domain itself (outside the 
confidence limits of the CT/CP) that this probability reaches unity. 
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Limitations 
The use of an isometric contraction model and NIRS-derived measures of m  O2 lead 
naturally to limitations in the extent to which we can generalize the current findings.  
Specifically, although the m  O2 measures produce qualitatively reasonable profiles of the m  O2 
response, they represent the interrogation of a relatively small and superficial volume of the 
vastus lateralis (20,22).  The same limitation is true for the measurement of arEMG, drawn again 
from the vastus lateralis.  The use of cuff occlusion to produce these measurements further 
limited the present protocol inasmuch as the measurements of fatigue-related variables could 
only take place before and at the immediate cessation of exercise.  We were not able to track the 
time course of fatigue, central or peripheral, although such measurements have been made 
previously in the heavy and severe domains (2).  Finally, the lack of a condition exclusively in 
the heavy intensity domain, as mentioned above, was chosen to limit the already considerable 
experimental burden on the participants.  Thus, we had to compare other conditions to the CT–2 
condition as a proxy for heavy intensity exercise.  We believe that this choice was justified as 
Figure 4 shows that the rate of peripheral fatigue development was identical to our previous 
studies in which contractions were performed demonstrably below the critical torque. 
 
Conclusions 
The present study demonstrated that the critical torque is not a sudden physiological 
threshold, based on the responses to isometric contractions within the confidence limits of the 
CT parameter estimate.  Specifically, when exercise was performed two standard errors above 
the point estimate of CT (~107% of CT), most of the observed responses appeared to be in the 
heavy intensity domain.  Such a low occurrence of severe-intensity responses suggests that the 
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confidence intervals themselves represent a region of physiological uncertainty, which we 
suggest is caused either by CT varying day-to-day by an amount represented by the confidence 
limits, or that heterogeneities in muscle recruitment, metabolism and/or blood flow can “trip” the 
system into a different domain of behavior at any intensity within the confidence limits.  In either 
case, we contend that the critical torque is most accurately defined as a continuous phase 
transition rather than a sudden threshold. Therefore, to ensure consistent physiological responses, 
exercise tasks should be performed outside the confidence limits associated with the CT or CP 
parameter estimate. 
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Figure Legends 
Figure 1 The rate of change in potentiated doublet torque as a function of the critical 
torque in two previous studies. 
The black circles are drawn from Burnley et al. (2) and the white squares are drawn from Pethick 
et al. (5).  The dashed lines represent the limits of present observations for sub- and supra-critical 
torque exercise.  Note the very slow decline in the potentiated doublet (and, thus, the slow 
development of peripheral fatigue) below the CT, but the increasingly rapid decline in doublet 
torque above the CT.  The primary aim of the present study was to fill the void between the two 
dashed lines illustrated on the figure. 
 
Figure 2 Group mean muscle oxygen consumption (Panel A), average rectified EMG (B), 
approximate entropy (C) and DFA α exponent (D) responses to contractions close to and 
above CT. 
The four circa-CT trials are represented (CT–2 to CT+2), along with the lowest severe-intensity 
predicting trial (S1).  Error bars are shown only shown at the conclusion of S1, CT–2 and CT+2 
for clarity (n = 12). 
 
Figure 3 Individual rates of change in the muscle oxygen consumption (A), average 
rectified EMG amplitude (B), approximate entropy (C), the maximal voluntary contraction 
(MVC) torque (E), potentiated doublet torque (E), and the DFA α exponent (F) during the 
circa-CT trials and the S1 trial. 
In these plots, the rates of change across conditions are normalized to the CT–2 condition, 
thereby eliminating false-positives/negatives created by applying sample statistics to the raw 
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individual responses.  The two lines on each panel represent the normalised CT–2 value and a 
change of two standard deviations towards severe-intensity exercise.  Severe responses were 
estimated as being greater than 2 SD from the normalized CT–2 response (n = 12). 
 
Figure 4 The rate of change in potentiated doublet torque as a function of the critical 
torque in the present study, plotted alongside the data from Figure 1.  Data are drawn from 
Burnley et al. (2; white circles), Pethick et al. (5; white squares) and the present study (black 
stars).  The intensity of each trial is plotted as a percentage of the critical torque in that study.  
Note the increase in the rate of decline in potentiated doublet torque above the CT in all studies, 
and the lack of a sudden decline in the potentiated doublet in close proximity to the CT (shown 
by the cluster of 4 stars at the top of the figure).  This suggests that a continuous phase transition, 
rather than a threshold, best describes the emergence of severe-intensity behavior above the CT. 
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Table 1. Voluntary torque, potentiated doublet torque, and voluntary activation during contractions within the confidence limits of 
(CT–2, CT–1, CT+1 and CT+2) and above (S1-S3) the CT. 
 
Parameter CT–2 CT–1 CT+1 CT+2 S1 S2 S3 
Target torque, N·m 57.2 ± 15.1 59.3 ± 15.1 63.5 ± 15.3 65.6 ± 15.5 85.5 ± 21.6 97.4 ± 25.0 112.2 ± 26.5 
Target torque, % MVC 24.8 ± 3.1 25.7 ± 3.0 27.6 ± 3.0 28.6 ± 3.0 37.1 ± 3.5 42.1 ± 3.3 48.8 ± 3.1 
Time to task end/failure, min 30.0 ± 0.0 30.0 ± 0.0 30.0 ± 0.0 29.5 ± 1.7 16.8 ± 2.8 9.7 ± 1.2 6.2 ± 0.9 
Global fatigue 
   Pre-exercise MVC, N·m 
   Peak MVC task end, N·m 
   Mean MVC task end, N·m 
   ∆M C/∆t, N·m·min-1 
 
245.8 ± 65.8 
197.8 ± 47.4 
167.6 ± 42.9
*† 
–1.5 ± 0.8  
 
245.7 ± 71.1 
189.4 ± 58.6 
162.1 ± 54.9
†
 
–1.7 ± 0.7 
 
247.2 ± 63.5 
172.2 ± 55.4 
147.1 ± 49.2
*†
 
–2.4 ± 0.9# 
 
243.3 ± 63.5 
 156.9 ± 56.7
#
 
133.3 ± 50.4
*†
 
–2.9 ± 1.7 
 
236.3 ± 71.3 
106.5 ± 44.0
#
 
86.0 ± 35.0
*
 
–7.9 ± 2.5# 
 
233.6 ± 62.1 
112.7 ± 45.2
#
 
98.8 ± 41.1
*
 
–12.5 ± 3.4# 
 
233.9 ± 66.6 
127.7 ± 41.5
#
 
108.7 ± 38.9
*
 
–17.1 ± 6.6# 
Peripheral fatigue 
   Pre-exercise doublet, N·m 
   Doublet task end, N·m 
   % Change task end 
   ∆doublet/∆t, N·m·min-1 
 
93.5 ± 31.1 
87.7 ± 29.2
*
 
6.0 ± 4.8 
–0.2 ± 0.2 
 
99.1 ± 33.0 
92.9 ± 32.6
*
 
6.4 ± 4.9 
–0.2 ± 0.2 
 
96.7 ± 31.9 
83.9 ± 28.3
*
 
13.3 ± 3.7 
–0.4 ± 0.2# 
 
93.1 ± 27.0 
79.8 ± 25.3
*#
 
14.2 ± 6.9 
–0.4 ± 0.3# 
 
94.4 ± 32.3 
66.4 ± 23.5
*#
 
29.3 ± 9.0 
–1.7 ± 0.8# 
 
94.0 ± 28.4 
67.6 ± 27.2
*#
 
29.4 ± 20.6 
–2.7 ± 1.1# 
 
91.2 ± 33.4 
65.6 ± 27.2
*#
 
27.5 ± 7.5 
–4.3 ± 2.6# 
Central fatigue 
   Pre-exercise VA, % 
   VA task end, % 
   % Change task end 
   ∆ A/∆t, %/min 
 
95.5 ± 3.7 
92.2 ± 3.6
*
 
3.5 ± 3.0 
–0.1 ± 0.1 
 
94.7 ± 2.6 
90.9 ± 5.1 
3.9 ± 4.6 
–0.1 ± 0.1 
 
94.5 ± 3.4 
84.9 ± 7.2
*
 
10.1 ± 7.1 
–0.3 ± 0.2 
 
94.7 ± 3.4 
85.6 ± 9.0
*
 
9.6 ± 9.0 
–0.3 ± 0.3 
 
94.9 ± 2.7 
77.1 ± 10.8
*#
 
18.8 ± 11.2 
–1.1 ± 0.7# 
 
93.3 ± 2.6 
80.5 ± 9.2
*#
 
13.6 ± 10.6 
–1.3 ± 1.0# 
 
93.8 ± 3.0 
80.3 ± 8.3
*# 
14.6 ± 7.3 
–2.3 ± 1.2# 
 
Values are means ± SD. MVC, maximal voluntary contraction; VA, voluntary activation; ∆, change; t, time. Symbols indicate a 
statistically significant difference compared to the following: 
*
value at task beginning, 
†
target torque, 
#
CT–2 (P < 0.05). 
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Table 2. Electromyogram amplitude, muscle oxygen uptake, variability, complexity and fractal scaling responses during contractions 
within the confidence limits of (CT-2, CT-1, CT+1 and CT+2) and above (S1-S3) the CT. 
 
Parameter CT-2 CT-1 CT+1 CT+2 S1 S2 S3 
   arEMG start, % MVC 
   arEMG  task end, % MVC 
   ∆arEMG/∆t, % MVC/min 
27.3 ± 7.2 
31.5 ± 8.1 
0.2 ± 0.2 
27.3 ± 5.6 
34.8 ± 8.7 
0.3 ± 0.3 
32.0 ± 9.0 
41.9 ± 12.0
*#
 
0.4 ± 0.3
#
 
32.5 ± 6.6 
48.4 ± 18.2
*#
 
0.6 ± 0.6 
42.4 ± 7.6 
68.7 ± 17.2
*#
 
1.8 ± 1.1
#
 
47.4 ± 8.7 
73.4 ± 13.9
*#
 
3.5 ± 1.4
#
 
61.6 ± 12.7 
80.8 ± 10.8
*#
 
4.8 ± 3.2
#
 
   m  O2 start, %·s
-1 
   m  O2 at task end, %·s
-1 
   ∆m  O2/∆t, %·s
-1 
1.65 ± 0.70 
1.98 ± 1.00
*
 
0.01 ± 0.01 
1.86 ± 0.80 
2.07 ± 0.92
*
 
0.01 ± 0.01 
2.24 ± 0.98 
2.67 ± 1.12
*#
 
0.02 ± 0.01 
2.45 ± 0.87 
3.10 ± 0.85
*#
 
0.03 ± 0.01 
2.43 ± 0.99 
3.27 ± 1.21
*#
 
0.06 ± 0.02
#
 
2.64 ± 1.12 
3.57 ± 1.21
*#
 
0.12 ± 0.08
#
 
2.60 ± 0.96 
3.33 ± 0.94
*#
 
0.19 ± 0.08
#
 
SD 
   SD at task beginning, N·m 
   SD at task failure, N·m 
   ∆SD/∆t, N·m·min-1 
 
1.33 ± 0.45 
1.64 ± 0.62
*
 
0.01 ± 0.01 
 
1.30 ± 0.44 
1.55 ± 0.37
*
 
0.01 ± 0.01 
 
1.37 ± 0.32 
1.87 ± 0.49
*
 
0.02 ± 0.01 
 
1.33 ± 0.32 
1.90 ± 0.80
*
 
0.02 ± 0.03 
 
1.87 ± 0.54 
4.71 ± 2.34
*#
 
0.19 ± 0.13
#
 
 
2.24 ± 0.51 
7.71 ± 1.21
*#
 
0.43 ± 0.35
#
 
 
2.95 ± 1.07 
7.85 ± 2.81
*#
 
1.20 ± 0.59
#
 
CV 
   CV at task beginning, % 
   CV at task failure, % 
    ΔC /Δt, %/min 
 
2.30 ± 0.68 
2.77 ± 1.04
*
 
0.02 ± 0.02 
 
2.27 ± 0.66 
2.65 ± 0.55
*
 
0.01 ± 0.02 
 
2.13 ± 0.41 
2.98 ± 0.66
*
 
0.03 ± 0.02 
 
2.03 ± 0.47 
2.84 ± 1.18
* 
0.03 ± 0.01 
 
2.30 ± 0.65 
6.01 ± 2.16
*#
 
0.21 ± 0.14
#
 
 
2.43 ± 0.64 
7.71 ± 1.21
*#
 
0.48 ± 0.30
#
 
 
2.66 ± 0.61 
8.29 ± 4.24
*#
 
1.38 ± 0.94
#
 
ApEn 
   ApEn at task beginning 
   ApEn at task failure 
   ∆ApEn/∆t  
 
0.56 ± 0.17 
0.51 ± 0.18
*
 
-0.002 ± 0.002 
 
0.60 ± 0.24 
0.54 ± 0.19
*
 
-0.002 ± 0.003 
 
0.55 ± 0.19 
0.45 ± 0.10
*
 
-0.001 ± 0.01 
 
0.56 ± 0.14 
0.44 ± 0.17
*
 
-0.005 ± 0.004 
 
0.46 ± 0.15 
0.16 ± 0.09
*#
 
-0.02 ± 0.01
#
 
 
0.41 ± 0.14 
0.15 ± 0.07
*#
 
-0.03 ± 0.01
#
 
 
0.32 ± 0.07 
0.07 ± 0.03
*#
 
-0.6 ± 0.3
#
 
DFA α 
   DFA α at task beginning 
   DFA α at task failure 
   ∆DFA α /∆t 
 
1.40 ± 0.06 
1.35 ± 0.10
*
 
-0.002 ± 0.003 
 
1.38 ± 0.10 
1.22 ± 0.25
*
 
-0.006 ± 0.008 
 
1.39 ± 0.06 
1.22 ± 0.25
*
 
0.006 ± 0.008 
 
1.37 ± 0.07 
1.33 ± 0.17 
0.001 ± 0.006 
 
1.40 ± 0.06 
1.56 ± 0.04
*#
 
0.01 ± 0.01
#
 
 
1.40 ± 0.05 
1.57 ± 0.09
*#
 
0.02 ± 0.02
#
 
 
1.45 ± 0.05 
1.65 ± 0.12
*#
 
0.05 ± 0.04
#
 
 
Values are means ± SD. arEMG, average rectified EMG, m  O2, muscle oxygen uptake, SD, standard deviation; CV, coefficient of 
variation; ApEn, approximate entropy; DFA α , detrended fluctuation analysis; ∆, change; t, time. Task start values are values from 2 
minutes into exercise, to account for primary amplitude of   O2 response. Symbols indicate a statistically significant difference 
compared to the following: 
*
value at task beginning, 
#
CT-2 (P < 0.05). 
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